SERINA THERAPEUTICS INC. (SER) Stock Balance Sheet
NYSEARCA:SER - NYSE Arca - US81751A1088 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 3.67M | 345.00K | 650.00K | 580.00K | 530.00K | |||
| Receivables | N/A | 57.00K | 0.00 | 30.00K | 330.00K | |||
| Other Current Assets | 2.00M | 352.00K | 1.80M | 1.63M | 1.43M | |||
| Total Current Assets | 5.68M | 754.00K | 2.45M | 2.23M | 2.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.05M | N/A | N/A | N/A | 0.00 | |||
| Intangibles | N/A | 607.00K | 740.00K | 870.00K | 1.59M | |||
| Other Non-Current Assets | N/A | 50.00K | 50.00K | 50.00K | 50.00K | |||
| Total Non-Current Assets | 1.05M | 11.21M | 790.00K | 920.00K | 1.65M | |||
| TOTAL ASSETS | 6.72M | 11.96M | 3.24M | 3.15M | 3.93M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 440.00K | |||
| Current Portion Of LT Debt. | N/A | 3.67M | 7.65M | 7.14M | 1.96M | |||
| Accrued Expenses | 1.43M | 763.00K | 470.00K | 580.00K | 900.00K | |||
| Accounts Payable | 744.00K | 1.41M | 570.00K | 190.00K | 760.00K | |||
| Other Current Liabilities | 193.00K | 66.00K | 1.40M | 1.06M | 1.31M | |||
| Total Current Liabilities | 2.37M | 5.91M | 10.08M | 8.97M | 5.36M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 693.00K | 10.48M | 6.06M | 3.90M | |||
| Other Non-Current Liabilities | 3.85M | N/A | N/A | 0.00 | 60.00K | |||
| Total Non-Current Liabilities | 3.72M | 582.00K | 10.37M | 6.02M | 3.68M | |||
| TOTAL LIABILITIES | 6.08M | 6.50M | 20.45M | 14.99M | 9.04M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -44.32M | -131.01M | -116.21M | -105.75M | -97.07M | |||
| Additional Paid In Capital | 44.96M | 136.48M | 98.99M | 93.91M | 91.81M | |||
| Minority Interest | -133.00K | -111.00K | -100.00K | -40.00K | -280.00K | |||
| Common Shares | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | 0.00 | N/A | 0.00 | 140.00K | |||
| Shares Outstanding | 9.42M | 1.08M | 37.95M | 37.94M | 37.69M | |||
| Tangible Book Value per Share | 0.07 | 4.51 | -0.47 | -0.33 | -0.18 | |||
| Total Shareholders' Equity | 641.00K | 5.47M | -17.21M | -11.83M | -5.12M | |||
| TOTAL LIABILITIES AND EQUITY | 6.72M | 11.96M | 3.24M | 3.15M | 3.93M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.13 | -0.61 | -0.51 | -0.85 | |||
| Current Ratio | 2.40 | 0.13 | 0.24 | 0.25 | 0.43 | |||
| Return On Assets (ROA) | -165.69% | -123.72% | -322.84% | -275.56% | -276.59% | |||
| Return On Equity (ROE) | -1738.07% | -270.67% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21